 | • レポートコード：B-GIR08C4184 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、経口固形投与製剤の世界市場について調べ、まとめました。種類別セグメントは、カプセル、粉末、錠剤等、用途別セグメントは、病院、診療所、その他等に区分しました。経口固形投与製剤の世界市場概観、企業動向、企業別経口固形投与製剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・経口固形投与製剤の市場概観 ・経口固形投与製剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・経口固形投与製剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・経口固形投与製剤の世界市場規模 ・経口固形投与製剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・経口固形投与製剤のアメリカ市場規模推移 ・経口固形投与製剤のカナダ市場規模推移 ・経口固形投与製剤のメキシコ市場規模推移 ・経口固形投与製剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・経口固形投与製剤のドイツ市場規模推移 ・経口固形投与製剤のイギリス市場規模推移 ・経口固形投与製剤のロシア市場規模推移 ・経口固形投与製剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・経口固形投与製剤の日本市場規模推移 ・経口固形投与製剤の中国市場規模推移 ・経口固形投与製剤の韓国市場規模推移 ・経口固形投与製剤のインド市場規模推移 ・経口固形投与製剤の東南アジア市場規模推移 ・経口固形投与製剤の南米市場分析（ブラジル、アルゼンチン等） ・経口固形投与製剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・経口固形投与製剤の種類別分析/販売量、売上、市場シェア（カプセル、粉末、錠剤） ・経口固形投与製剤の用途別分析/市場規模（病院、診療所、その他） ・経口固形投与製剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・経口固形投与製剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Oral Solid Dosage Pharmaceutical Formulation is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oral Solid Dosage Pharmaceutical Formulation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZeneca Plc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Gilead Sciences
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
AbbVie Inc.
Boehringer Ingelheim GmbH
Hoffman-La-Roche Ltd.
Johnson & Johnson
Biogen Inc.
Bayer AG
Teva Pharmaceticals
Amgen Inc.
Takeda Pharmaceutical Company Ltd.
Otsuka Pharmaceutical Co., Ltd.
Shire Plc.
Celgene Corporation
Astellas Pharma Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Capsules
Powders
Tablets
Market Segment by Applications, can be divided into
Hospitals
Clinics
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Solid Dosage Pharmaceutical Formulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Solid Dosage Pharmaceutical Formulation, with price, sales, revenue and global market share of Oral Solid Dosage Pharmaceutical Formulation in 2017 and 2018.
Chapter 3, the Oral Solid Dosage Pharmaceutical Formulation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Solid Dosage Pharmaceutical Formulation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oral Solid Dosage Pharmaceutical Formulation market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oral Solid Dosage Pharmaceutical Formulation sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Oral Solid Dosage Pharmaceutical Formulation Introduction
1.2 Market Analysis by Type
1.2.1 Capsules
1.2.2 Powders
1.2.3 Tablets
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca Plc.
2.1.1 Business Overview
2.1.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bristol-Myers Squibb Company
2.2.1 Business Overview
2.2.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly and Company
2.3.1 Business Overview
2.3.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Gilead Sciences
2.4.1 Business Overview
2.4.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck & Co. Inc.
2.5.1 Business Overview
2.5.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis AG
2.6.1 Business Overview
2.6.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pfizer Inc.
2.7.1 Business Overview
2.7.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 AbbVie Inc.
2.8.1 Business Overview
2.8.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Boehringer Ingelheim GmbH
2.9.1 Business Overview
2.9.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Hoffman-La-Roche Ltd.
2.10.1 Business Overview
2.10.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Johnson & Johnson
2.11.1 Business Overview
2.11.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Johnson & Johnson Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Biogen Inc.
2.12.1 Business Overview
2.12.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Biogen Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Bayer AG
2.13.1 Business Overview
2.13.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bayer AG Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Teva Pharmaceticals
2.14.1 Business Overview
2.14.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Teva Pharmaceticals Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Amgen Inc.
2.15.1 Business Overview
2.15.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Amgen Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Takeda Pharmaceutical Company Ltd.
2.16.1 Business Overview
2.16.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Takeda Pharmaceutical Company Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Otsuka Pharmaceutical Co., Ltd.
2.17.1 Business Overview
2.17.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Otsuka Pharmaceutical Co., Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Shire Plc.
2.18.1 Business Overview
2.18.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shire Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Celgene Corporation
2.19.1 Business Overview
2.19.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Celgene Corporation Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Astellas Pharma Inc.
2.20.1 Business Overview
2.20.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Astellas Pharma Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Solid Dosage Pharmaceutical Formulation Manufacturer Market Share in 2018
3.3.2 Top 6 Oral Solid Dosage Pharmaceutical Formulation Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis by Regions
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Regions (2014-2019)
4.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Regions (2014-2019)
4.2 North America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
4.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
4.5 South America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
5 North America Oral Solid Dosage Pharmaceutical Formulation by Country
5.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
5.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2014-2019)
5.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2014-2019)
5.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
5.3 Canada Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
5.4 Mexico Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
6 Europe Oral Solid Dosage Pharmaceutical Formulation by Country
6.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2014-2019)
6.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2014-2019)
6.2 Germany Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
6.3 UK Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
6.4 France Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
6.5 Russia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
6.6 Italy Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
7 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation by Country
7.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2014-2019)
7.2 China Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
7.3 Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
7.4 Korea Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
7.5 India Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
8 South America Oral Solid Dosage Pharmaceutical Formulation by Country
8.1 South America Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
8.1.1 South America Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2014-2019)
8.1.2 South America Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2014-2019)
8.2 Brazil Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
8.3 Argentina Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
8.4 Colombia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
9 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by Countries
9.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
9.3 Turkey Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
9.4 Egypt Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
9.5 Nigeria Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
9.6 South Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
10 Global Oral Solid Dosage Pharmaceutical Formulation Market Segment by Type
10.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (2014-2019)
10.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2014-2019)
10.2 Capsules Sales Growth and Price
10.2.1 Global Capsules Sales Growth (2014-2019)
10.2.2 Global Capsules Price (2014-2019)
10.3 Powders Sales Growth and Price
10.3.1 Global Powders Sales Growth (2014-2019)
10.3.2 Global Powders Price (2014-2019)
10.4 Tablets Sales Growth and Price
10.4.1 Global Tablets Sales Growth (2014-2019)
10.4.2 Global Tablets Price (2014-2019)
11 Global Oral Solid Dosage Pharmaceutical Formulation Market Segment by Application
11.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
12.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate (2019-2024)
12.2 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Regions (2019-2024)
12.2.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
12.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
12.2.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
12.2.4 South America Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
12.2.5 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
12.3 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Type (2019-2024)
12.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2019-2024)
12.3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Type (2019-2024)
12.4 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Application (2019-2024)
12.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2019-2024)
12.4.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Oral Solid Dosage Pharmaceutical Formulation Picture
Table Product Specifications of Oral Solid Dosage Pharmaceutical Formulation
Figure Global Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Types in 2018
Table Oral Solid Dosage Pharmaceutical Formulation Types for Major Manufacturers
Figure Capsules Picture
Figure Powders Picture
Figure Tablets Picture
Figure Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure France Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure UK Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure China Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure India Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2014-2024)
Table AstraZeneca Plc. Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hoffman-La-Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Johnson & Johnson Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Inc. Basic Information, Manufacturing Base and Competitors
Table Biogen Inc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Biogen Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Bayer AG Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceticals Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceticals Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Teva Pharmaceticals Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen Inc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Amgen Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Pharmaceutical Company Ltd. Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Company Ltd. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Takeda Pharmaceutical Company Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Otsuka Pharmaceutical Co., Ltd. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Otsuka Pharmaceutical Co., Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Plc. Basic Information, Manufacturing Base and Competitors
Table Shire Plc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Shire Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Celgene Corporation Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Inc. Oral Solid Dosage Pharmaceutical Formulation Type and Applications
Table Astellas Pharma Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturer (2017-2018)
Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Manufacturer in 2017
Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Manufacturer in 2018
Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturer (2017-2018)
Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Manufacturer in 2017
Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Manufacturer in 2018
Figure Top 3 Oral Solid Dosage Pharmaceutical Formulation Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Oral Solid Dosage Pharmaceutical Formulation Manufacturer (Revenue) Market Share in 2018
Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales by Regions (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Regions (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Regions (2014-2019)
Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Regions in 2014
Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Regions in 2018
Figure North America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure South America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure North America Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2014-2019)
Table North America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2014-2019)
Table North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2014-2019)
Figure North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2014
Figure North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2018
Table North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2014-2019)
Table North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2014-2019)
Figure North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2014
Figure North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2018
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Canada Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Mexico Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2014-2019)
Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2014-2019)
Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2014-2019)
Table Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2014-2019)
Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2017
Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2018
Figure Germany Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure UK Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure France Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Russia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Italy Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2014-2019)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries 2018
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2014-2019)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries 2018
Figure China Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Korea Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure India Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure South America Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2014-2019)
Table South America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2014-2019)
Table South America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2014-2019)
Figure South America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2018
Table South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2014-2019)
Table South America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2014-2019)
Figure South America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2018
Figure Brazil Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Argentina Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Colombia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2014-2019)
Table Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2018
Table Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2014-2019)
Table Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2014
Figure Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2018
Figure Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure UAE Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Egypt Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure Nigeria Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Figure South Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Type (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2014-2019)
Figure Global Capsules Sales Growth (2014-2019)
Figure Global Capsules Price (2014-2019)
Figure Global Powders Sales Growth (2014-2019)
Figure Global Powders Price (2014-2019)
Figure Global Tablets Sales Growth (2014-2019)
Figure Global Tablets Price (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2014-2019)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Application (2014-2019)
Figure Global Clinics Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate (2019-2024)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Regions (2019-2024)
Table Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Regions (2019-2024)
Figure North America Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
Figure Europe Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
Figure Asia-Pacific Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
Figure South America Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
Figure Middle East and Africa Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2019-2024)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2019-2024)
Table Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Type (2019-2024)
Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2019-2024)
Table Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の経口固形投与製剤市場2019 The global Oral Solid Dosage Pharmaceutical Formulation market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Oral Solid Dosage Pharmaceutical Formulation market status and forecast, categorizes t…- 世界の経口固形製剤受託製造市場：市場規模・現状・予測 In 2018, the global Oral Solid Dosage Contract Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Oral Solid Dosage Contract Manufacturing status, future forecast, growth o…
- 経口補水塩の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Oral Rehydration Salt is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Oral Rehydration Salt in gl…
- 世界の錠剤およびカプセル包装市場2019 The global Tablets and Capsules Packaging market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Tablets and Capsules Packaging market status and forecast, categorizes the global Tablets and Capsul…
- 低用量ハイドレート阻害剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition. Scope of the Report: The worldwide market for Low dosage Hydrate Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, wi…